Biologic License Application STN BL 125036 - Biogen Alefacept for the Treatment of Chronic Plaque Psoriasis

6/4/02


Click here to start


Table of Contents

Biologic License Application STN BL 125036 - Biogen Alefacept for the Treatment of Chronic Plaque Psoriasis

Alefacept BLA Review Committee

Alefacept

The Interaction Between T Cells and Antigen-Presenting Cells

Alefacept: Mechanism of Action (1)

Alefacept: Mechanism of Action (2)

CD2 Expression

Alefacept - Biogen (STN BL 125036)

Author: E.Bonvini